Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure Lumbar spine MRI obtained on hospital day 2 demonstrating nerve root enhancement and evolution of CSF and electrodiagnostic findings Lumbar spine.

Published byMaría Victoria Jiménez Cruz Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure Lumbar spine MRI obtained on hospital day 2 demonstrating nerve root enhancement and evolution of CSF and electrodiagnostic findings Lumbar spine."— Presentation transcript:

1 Figure Lumbar spine MRI obtained on hospital day 2 demonstrating nerve root enhancement and evolution of CSF and electrodiagnostic findings Lumbar spine MRI obtained on hospital day 2 demonstrating nerve root enhancement and evolution of CSF and electrodiagnostic findings (A) Axial T2-weighted image showing nerve roots (white arrows). (B) Axial T1-weighted image at the same level precontrast and (C) postcontrast showing gadolinium enhancement of nerve roots (white arrows). (D) Inset showing the nerve root enhancement at 2× magnification. (E) CSF analysis from days 4 and 12 demonstrating the marked increase in CSF protein between the 2 time points, much higher than values previously reported. (F) Pertinent findings from electrodiagnostic studies performed on hospital days 3 and 16 showing changes consistent with a lumbosacral polyradiculopathy vs anterior horn cell disease. CMAP = compound motor action potential; Fibs = fibrillation potentials; Ins'l = insertional; MUPs = motor unit potentials; NC = nucleated cells; PSWs = positive sharp waves; SNAP = sensory nerve action potential. Baijayanta Maiti, and Robert C. Bucelli Neurol Neuroimmunol Neuroinflamm 2014;1:e8 © 2014 American Academy of Neurology

Download ppt "Figure Lumbar spine MRI obtained on hospital day 2 demonstrating nerve root enhancement and evolution of CSF and electrodiagnostic findings Lumbar spine."

Similar presentations

Neurology Resident and Fellow Section

Neurology Resident and Fellow Section
Figure 1 Initial brain imaging (A–C) patient 1; (D–F) patient 2; (G–I) patient 3; (J–L) patient 4; and (M) patient 2. Initial brain imaging (A–C) patient.

Figure 1 Initial brain imaging (A–C) patient 1; (D–F) patient 2; (G–I) patient 3; (J–L) patient 4; and (M) patient 2. Initial brain imaging (A–C) patient.
Figure 1 Brain MRI findings in the present case

Figure 1 Brain MRI findings in the present case
Figure 4. Brain imaging and neuropathologic demonstration of Epstein-Barr virus (EBV) encephalitis in patient PT-10 Brain imaging and neuropathologic demonstration.

Figure 4. Brain imaging and neuropathologic demonstration of Epstein-Barr virus (EBV) encephalitis in patient PT-10 Brain imaging and neuropathologic demonstration.
Figure Cervical spinal cord area assessment

Figure Cervical spinal cord area assessment
Figure 2 Evolution of MRI abnormalities in faciobrachial dystonic seizures Axial fluid- attenuated inversion recovery (FLAIR)-weighted images from patient.

Figure 2 Evolution of MRI abnormalities in faciobrachial dystonic seizures Axial fluid- attenuated inversion recovery (FLAIR)-weighted images from patient.
Figure 2 Orbital MRI findings One-third of myelin oligodendrocyte glycoprotein antibody–positive patients revealed extensive enhancement patterns that.

Figure 2 Orbital MRI findings One-third of myelin oligodendrocyte glycoprotein antibody–positive patients revealed extensive enhancement patterns that.
Figure Neuroimaging and pathology

Figure Neuroimaging and pathology
Figure 1 Coronal MRI images showing the evolution of white matter abnormality and atrophy of patient 1 Coronal MRI images showing the evolution of white.

Figure 1 Coronal MRI images showing the evolution of white matter abnormality and atrophy of patient 1 Coronal MRI images showing the evolution of white.
Figure Facial photograph during headache attack and brain and upper cervical cord MRI Facial photograph during headache attack and brain and upper cervical.

Figure Facial photograph during headache attack and brain and upper cervical cord MRI Facial photograph during headache attack and brain and upper cervical.
Figure 3 Example of venous narrowing

Figure 3 Example of venous narrowing
Figure Immune checkpoint inhibitor–induced encephalitis before and after treatment with natalizumab Immune checkpoint inhibitor–induced encephalitis before.

Figure Immune checkpoint inhibitor–induced encephalitis before and after treatment with natalizumab Immune checkpoint inhibitor–induced encephalitis before.
Figure 1 MRI head in faciobrachial dystonic seizures (A) Axial fluid-attenuated inversion recovery image from patient 3 in table 2 shows T2-weighted hyperintensity.

Figure 1 MRI head in faciobrachial dystonic seizures (A) Axial fluid-attenuated inversion recovery image from patient 3 in table 2 shows T2-weighted hyperintensity.
Figure 1. Prebiopsy and postbiopsy MRI

Figure 1. Prebiopsy and postbiopsy MRI
A 30-year-old woman with Zika virus infection with Guillain-Barré syndrome. A 30-year-old woman with Zika virus infection with Guillain-Barré syndrome.

A 30-year-old woman with Zika virus infection with Guillain-Barré syndrome. A 30-year-old woman with Zika virus infection with Guillain-Barré syndrome.
Figure 1. Brain MRI follow-up of Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis treated with rituximab Brain MRI follow-up.

Figure 1. Brain MRI follow-up of Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis treated with rituximab Brain MRI follow-up.
Figure Longitudinal MRI study data demonstrating evolution of central pontine myelinolysis(A, B) Axial T2-weighted MRI of the brain from January 9, 2014,

Figure Longitudinal MRI study data demonstrating evolution of central pontine myelinolysis(A, B) Axial T2-weighted MRI of the brain from January 9, 2014,
Figure MRI and leptomeningeal biopsy findings in Vogt-Koyanagi-Harada syndrome involving the cerebellopontine angle(A) Coronal and (B) axial gadolinium-enhanced.

Figure MRI and leptomeningeal biopsy findings in Vogt-Koyanagi-Harada syndrome involving the cerebellopontine angle(A) Coronal and (B) axial gadolinium-enhanced.
Figure 1 Quantitative spinal cord MRI maps and segmentations

Figure 1 Quantitative spinal cord MRI maps and segmentations
Figure 1 Cerebral MRI during the disease course Cerebral MRI with multiple cerebral supratentorial lesions during the disease course: periventricular lesions.

Figure 1 Cerebral MRI during the disease course Cerebral MRI with multiple cerebral supratentorial lesions during the disease course: periventricular lesions.

Similar presentations

Ads by Google